Dr. Susan Meier-Davis, DVM, PhD, DABT, RAC had been Vice President of Safety at Apricus Biosciences, Inc. since February 2012. Dr. Meier-Davis managed the pharmacovigilance activities and nonclinical/clinical safety programs for Apricus Biosciences. She has more than 15 years of wide-ranging experience in the pharmaceutical industry having actively participated in transdermal, anti-infective, Alzheimer’s disease, chemotherapy and cardiovascular drug development programs.
+44-20-4587-4809